Pfizer's Geodon gets expanded FDA approval

AP News
Posted: Nov 20, 2009 2:15 PM

Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.

The new approval covers use of Geodon as an adjunct to lithium or valproate.

The drug is already approved as a treatment for schizophrenia and bipolar disorder.

Shares of Pfizer rose 20 cents to $18.31 in afternoon trading.